These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9856663)

  • 1. Strontium-89 (89Sr) analgesia for rare thymic carcinoid tumor with bony metastases.
    Vishne TH; Ron IG
    Am J Clin Oncol; 1998 Dec; 21(6):602-4. PubMed ID: 9856663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement.
    Kraeber-Bodéré F; Campion L; Rousseau C; Bourdin S; Chatal JF; Resche I
    Eur J Nucl Med; 2000 Oct; 27(10):1487-93. PubMed ID: 11083537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic radionuclide therapy in pain palliation.
    Liepe K; Runge R; Kotzerke J
    Am J Hosp Palliat Care; 2005; 22(6):457-64. PubMed ID: 16323716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strontium 89 therapy for the palliation of pain due to osseous metastases.
    Robinson RG; Preston DF; Schiefelbein M; Baxter KG
    JAMA; 1995 Aug; 274(5):420-4. PubMed ID: 7542352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strontium-89 chloride in the treatment of bone metastases from breast cancer.
    Baziotis N; Yakoumakis E; Zissimopoulos A; Geronicola-Trapali X; Malamitsi J; Proukakis C
    Oncology; 1998; 55(5):377-81. PubMed ID: 9732212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strontium-89 for palliation of pain from bone metastases in patients with prostate and breast cancer.
    Pons F; Herranz R; Garcia A; Vidal-Sicart S; Conill C; Grau JJ; Alcover J; Fuster D; Setoain J
    Eur J Nucl Med; 1997 Oct; 24(10):1210-4. PubMed ID: 9323260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of strontium-89 in the analgesic treatment of bone metastases].
    Hayek D; Ritschard J; Zwahlen A; Courvoisier B; Donath A
    Schweiz Med Wochenschr; 1980 Aug; 110(31-32):1154-9. PubMed ID: 7444409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone pain palliation with strontium-89 in breast cancer patients with bone metastases and refractory bone pain.
    Berna L; Carrio I; Alonso C; Ferré J; Estorch M; Torres G
    Eur J Nucl Med; 1995 Oct; 22(10):1101-4. PubMed ID: 8542891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The correlation between palliation of bone pain by intravenous strontium-89 and external beam radiation to linked field in patients with osteoblastic bone metastases.
    Ron IG; Stav O; Vishne T; Evan-Sapir E; Soyfer V; Agai R; Cherny N; Kovner F
    Am J Clin Oncol; 2004 Oct; 27(5):500-4. PubMed ID: 15596920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicentre observational study of radionuclide therapy in patients with painful bone metastases of prostate cancer.
    Dafermou A; Colamussi P; Giganti M; Cittanti C; Bestagno M; Piffanelli A
    Eur J Nucl Med; 2001 Jul; 28(7):788-98. PubMed ID: 11504074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Strontium-89 therapy and subarachnoid phenol block successfully eliminated intractable pain of metastasis in the patient with advanced urachal carcinoma].
    Arakawa Y; Inoue D; Sakuyama T; Nagasaki E; Aiba K
    Gan To Kagaku Ryoho; 2011 Dec; 38 Suppl 1():59-60. PubMed ID: 22189321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [89Sr Therapy for pain relief in patients with bone metastases].
    Koizumi K; Arbab AS; Toyama K; Shirasu M; Osawa S; Araki T; Yamaguchi M; Onishi H; Araki T; Arai T; Komatsu H; Ueno A; Nokata H
    Kaku Igaku; 1996 Nov; 33(11):1243-8. PubMed ID: 8986064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Strontium chloride (89Sr-chloride) fractional injection method for bone metastases treatment].
    Fomin DK; Smirnov IuN; Tararukhina OB; Nazarov AA
    Vopr Onkol; 2012; 58(1):116-8. PubMed ID: 22629840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radioactive strontium for treating incurable pain in skeletal neoplasms (author's transl)].
    Firusian N; Schmidt CG
    Dtsch Med Wochenschr; 1973 Dec; 98(49):2347-51. PubMed ID: 4763877
    [No Abstract]   [Full Text] [Related]  

  • 15. Relative efficacy of 32P and 89Sr in palliation in skeletal metastases.
    Nair N
    J Nucl Med; 1999 Feb; 40(2):256-61. PubMed ID: 10025832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of strontium-89 in endocrine-refractory prostate cancer metastatic to bone. Provincial Genitourinary Cancer Disease Site Group.
    Brundage MD; Crook JM; Lukka H
    Cancer Prev Control; 1998 Apr; 2(2):79-87. PubMed ID: 9765768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of strontium-89 in the analgesic treatment of cancer patients with bone metastases].
    Baranauskas Z; Valuckas K; Aleknavicius E; Jankevicius F; Burneckis A; Paviloniene I
    Medicina (Kaunas); 2006; 42(1):11-4. PubMed ID: 16467608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrepancy between clinical symptoms and Tc-99m MDP bone scan findings before and after strontium-89 therapy for metastatic bone pain of prostate carcinoma.
    Sun SS; Tsai SC; Hsieh JF; Lee JK; Kao CH
    Clin Nucl Med; 2001 Feb; 26(2):167-9. PubMed ID: 11201488
    [No Abstract]   [Full Text] [Related]  

  • 19. Systemic radionuclide therapy with strontium chloride Sr 89 for painful skeletal metastases in prostate and breast cancer.
    Patel BR; Flowers WM
    South Med J; 1997 May; 90(5):506-8. PubMed ID: 9160068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 89Strontium in bone metastases from hormone resistant prostate cancer: palliation effect and biochemical changes.
    Fosså SD; Paus E; Lochoff M; Backe SM; Aas M
    Br J Cancer; 1992 Jul; 66(1):177-80. PubMed ID: 1379058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.